https://nl.marketscreener.com/koers/aandeel/ESSA-PHARMA-INC-44458541/nieuws/ESSA-Pharma-Inc-Kondigt-de-start-aan-van-een-Fase-2-studie-waarin-Masofaniten-EPI-7386-wordt-gee-44867466/?utm_source=telegram&utm_medium=social&utm_campaign=share